Cirevetmab

Tax included
Cirevetmab (ZTS-00521426) is an immunoglobulin G2-kappa, Canis lupus familiaris TGFB1 caninized monoclonal antibody. Cirevetmab is an immunomodulator.
MedChemExpress 
HY-P99606

Data sheet

Size
Multiple sizes
Reactivity
TGF-beta/Smad
Application
COVID-19-immunoregulation
CAS
2473240-98-9